Developer docs
API playgroundTry for free, no card

Search company profiles

US Pharma Lab

Full company profile

uuid0008h6c

Namestring
US Pharma Lab
Legal namestring
US Pharma Lab
Websiteurl
uspl.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

US Pharma Lab (USPL) is a B2B contract developer, manufacturer, and supplier of premium dietary supplement ingredients, founded in 1996 and headquartered in North Brunswick, New Jersey. The company operates a full turnkey model covering formulation development, manufacturing, and packaging for brand clients in the dietary supplement, medical food, and specialty nutrition categories. Since 2023, USPL has functioned as the North American headquarters and manufacturing hub of Italy-based Biofarma Group, giving the company a multi-site parent footprint spanning Italy, France, and the United States.

The technical platform is centered on a broad portfolio of delivery forms — tri-layer and bi-layer tablets, extended/modified-release tablets, chewable and orally dispersible tablets (ODT), hard capsules, bulk and ready-to-drink powders, beadlets (500–2000 µm multiparticulate matrix), and mini-tablets with personalized release profiles — supported by proprietary taste and odor masking systems and a tablet-in-capsule technology. Probiotic manufacturing is operated in a dedicated 25% RH-controlled environment for stability assurance. The facility runs 12 dedicated packaging lines covering bottles, cartons, blister cards, boxes, stick packs, in-line blister printing, and probiotic-specific packaging. Regulatory depth is a defining feature: the company holds FDA Registration (dietary supplements and cosmetics), NSF, NSF GRMA, USP, TGA (Australia), Halal, Kosher, UL (Dietary Supplements and Specialty Dietary Ingredients), EcoCert, and a New Jersey State manufacturing license.

US Pharma Lab operates a pure B2B enterprise sales model targeting dietary supplement brands through direct field engagement. Revenue is generated via custom contract manufacturing services priced on a quote basis, which is not publicly disclosed. Customer logos, contract values, and revenue figures are not disclosed in available sources. Founder Ashok Luhadia is the only named leadership figure; no broader management team, headcount trend, or financial disclosures are available. The company has no disclosed AI/ML capabilities, no API platform, and no app or SDK products — its competitive positioning is grounded in process engineering, dosage-form innovation, regulatory credentials, and parent-group scale rather than software or data assets.

Short descriptiontext

US Pharma Lab is a B2B contract manufacturer of premium dietary supplement ingredients, founded in 1996 in North Brunswick, NJ, and operating since 2023 as the North American hub of Italy's Biofarma Group. It serves supplement brands with turnkey development, probiotic manufacturing, and 12 dedicated packaging lines.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNorth Brunswick, United States
HQ citystring
North Brunswick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract dietary supplement manufacturing, custom tablet development, probiotic manufacturing services, premix formulations, turnkey packaging solutions
Industry5 codes
PRIMARYCRADAGAC
Multivitamins & Daily Packs
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYAFAHAHAJ
Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes)
Agriculture & Food Production/Dairy Processing/Infant Formula & Specialized Dairy Nutrition Manufacturing
SECONDARYCRADAOAM
Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes)
NAICS code1 code
  • Food Manufacturing311
SIC code2 codes
  • Food And Kindred Products2000
  • Miscellaneous Food Preparations & Kindred Products2090
Product category
Contract Dietary Supplement Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Custom Dietary Supplement Manufacturing
TypeProfessional Services
Description

B2B contract manufacturing services for dietary supplement brands, providing custom development, production, and packaging of premium supplement ingredients and finished products in various delivery forms.

biofarmagroup.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

USPL is a custom developer, manufacturer, and supplier of premium dietary supplement ingredients, premixes, and finished products, serving nutraceutical brands across nine dosage formats (tablets, hard capsules, chewable/ODT, powders, beadlets, mini-tablets, probiotics, solid food supplements, and medical foods). The company also offers turnkey packaging solutions designed to address challenges in product formulation and stability for B2B clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Global outreach spanning three continents
Product overview1 text field

US Pharma Lab is a custom developer, manufacturer, and supplier of premium dietary supplement ingredients. The company offers a comprehensive portfolio of delivery forms including tri-layer and bi-layer tablets, extended-release/modified-release tablets, chewable and orally dispersible tablets (ODT), hard capsules, and customizable powders. The product portfolio is supported by proprietary technologies including taste & odor masking systems, beadlets, mini-tablets with personalized release technology, and Tablet-in-Capsule technology. US Pharma Lab specializes in probiotic-based supplements manufactured in dedicated controlled-environment facilities, along with solid food supplements and medical foods. The company provides complete turnkey operations including production and 12 dedicated packaging lines for bottles, cartons, blister cards, boxes, and stick packs.

Product and service9 records
1Custom Tablets (Tri-layer/Bi-layer, Extended-Release, Modified-Release, Chewable, ODT)
CategoryTablet Manufacturing
Description

Custom tablet development and manufacturing covering tri-layer and bi-layer constructions, extended- and modified-release profiles, plus chewable and orally dispersible tablet (ODT) formats for nutraceutical and dietary supplement brand customers.

2Hard Capsules
CategoryCapsule Manufacturing
Description

Custom hard capsule manufacturing as one of USPL's core dosage formats for dietary supplement brands.

3Powder Formulations (Bulk, Ready-to-Drink, Customizable)
CategoryPowder Formulations
Description

Development and production of bulk powders, ready-to-drink powder formulations, and customizable powder products for supplement and functional-food customers.

4Beadlet Supplements
CategoryBeadlet Technology
Description

Beadlet technology offering that enables delivery of actives in a beadlet form for dietary supplement brands seeking differentiated formats.

5Mini-Tablets with Personalized Release Technology
CategoryMini-Tablet Manufacturing
Description

Mini-tablet dosage format using USPL's personalized release technology for nutraceutical customers seeking precise, customizable release profiles.

6Probiotic Supplement Manufacturing
CategoryProbiotic Manufacturing
Description

Probiotic supplement manufacturing conducted in dedicated 25% relative humidity controlled rooms to protect probiotic viability and deliver reliable potency for brand customers.

7Solid Food Supplements
CategorySolid Food Supplement Manufacturing
Description

Solid food-form supplement products offered as one of USPL's nine dosage formats for nutraceutical and functional food brands.

8Medical Foods
CategoryMedical Food Manufacturing
Description

Medical food products within USPL's portfolio, targeted at nutraceutical and clinical nutrition customers.

9Turnkey Packaging Solutions
CategoryTurnkey Packaging Services
Description

Complete turnkey packaging services designed to address product-development challenges for B2B customers, including execution alongside custom manufacturing programs.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

US Pharma Lab joined Biofarma Group in 2023, becoming part of a larger pharmaceutical manufacturing group with multiple manufacturing sites including facilities in Italy and France. The partnership provides USPL with enhanced global scale and resources while serving as Biofarma Group's North American headquarters and manufacturing hub.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Parent company and direct CDMO peer. Biofarma Group operates multiple manufacturing sites across Italy and France producing dietary supplements, probiotics, and medical foods using the same delivery-form technologies (mini-tablets, beadlets, ODT) and certifications. Most direct comparable because it shares product formats, customer base (supplement brands), and regulatory playbook.

TypeBroad incumbent
Description

Large European CDMO offering solid, semi-solid, and liquid dosage forms for pharmaceuticals and dietary supplements. Comparable to USPL as a contract developer and manufacturer serving brand clients with turnkey operations and multi-format capabilities, though Aenova is broader in pharma.

TypeBroad incumbent
Description

Global CDMO with softgel, oral solid, and biologics capabilities serving pharma and consumer health. Overlaps with USPL in dietary supplement contract manufacturing, advanced oral dosage forms (including mini-tablet and modified-release technologies), and brand-client services.

4Lonza Capsules & Health Ingredients
TypeBroad incumbent
Description

Lonza operates a major capsules and health ingredients business including CDMO services for dietary supplements with beadlet and lipid-based delivery technology. Direct overlap with USPL's beadlet, capsule, and probiotic ingredient capabilities serving supplement brand customers.

5Recipharm
TypeBroad incumbent
Description

European-headquartered CDMO with solid dose and softgel capabilities for pharma and consumer health. Comparable to USPL in turnkey contract manufacturing of oral solid supplements and probiotics, though with a broader pharma mix.

TypeBroad incumbent
Description

French CDMO with multiple sites producing solid dosage forms including dietary supplements and probiotics for brand clients. Comparable as a multi-site contract manufacturer offering turnkey supplement production with strong European regulatory footprint.

7Fareva
TypeBroad incumbent
Description

Global contract manufacturer with significant dietary supplement and probiotic capabilities across Europe and the Americas. Comparable to USPL in CDMO model, multi-format oral dose manufacturing, and probiotic specialization.

TypeDirect peer
Description

Provider of nutritional premixes, custom ingredient solutions, and finished supplement manufacturing for brand customers. Comparable to USPL's premix, ingredient supply, and contract manufacturing business, including customized formulations for supplement brands.

9Procaps Group
TypeDirect peer
Description

Latin American CDMO specializing in softgel, capsule, and tablet dietary supplement manufacturing for global brands. Comparable to USPL as a turnkey supplement contract manufacturer serving multinational brand clients with advanced delivery forms.

TypeDirect peer
Description

CDMO offering end-to-end development and manufacturing of dietary supplements including gummies, softgels, and probiotics. Comparable to USPL in turnkey contract manufacturing, probiotic capabilities, and serving supplement brand customers globally.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance12 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

US Pharma Lab

Contract Dietary Supplement Manufacturinguspl.com

US Pharma Lab is a B2B contract manufacturer of premium dietary supplement ingredients, founded in 1996 in North Brunswick, NJ, and operating since 2023 as the North American hub of Italy's Biofarma Group. It serves supplement brands with turnkey development, probiotic manufacturing, and 12 dedicated packaging lines.

What US Pharma Lab does

US Pharma Lab (USPL) is a B2B contract developer, manufacturer, and supplier of premium dietary supplement ingredients, founded in 1996 and headquartered in North Brunswick, New Jersey. The company operates a full turnkey model covering formulation development, manufacturing, and packaging for brand clients in the dietary supplement, medical food, and specialty nutrition categories. Since 2023, USPL has functioned as the North American headquarters and manufacturing hub of Italy-based Biofarma Group, giving the company a multi-site parent footprint spanning Italy, France, and the United States.

The technical platform is centered on a broad portfolio of delivery forms — tri-layer and bi-layer tablets, extended/modified-release tablets, chewable and orally dispersible tablets (ODT), hard capsules, bulk and ready-to-drink powders, beadlets (500–2000 µm multiparticulate matrix), and mini-tablets with personalized release profiles — supported by proprietary taste and odor masking systems and a tablet-in-capsule technology. Probiotic manufacturing is operated in a dedicated 25% RH-controlled environment for stability assurance. The facility runs 12 dedicated packaging lines covering bottles, cartons, blister cards, boxes, stick packs, in-line blister printing, and probiotic-specific packaging. Regulatory depth is a defining feature: the company holds FDA Registration (dietary supplements and cosmetics), NSF, NSF GRMA, USP, TGA (Australia), Halal, Kosher, UL (Dietary Supplements and Specialty Dietary Ingredients), EcoCert, and a New Jersey State manufacturing license.

US Pharma Lab operates a pure B2B enterprise sales model targeting dietary supplement brands through direct field engagement. Revenue is generated via custom contract manufacturing services priced on a quote basis, which is not publicly disclosed. Customer logos, contract values, and revenue figures are not disclosed in available sources. Founder Ashok Luhadia is the only named leadership figure; no broader management team, headcount trend, or financial disclosures are available. The company has no disclosed AI/ML capabilities, no API platform, and no app or SDK products — its competitive positioning is grounded in process engineering, dosage-form innovation, regulatory credentials, and parent-group scale rather than software or data assets.

US Pharma Lab firmographics

Firmographics
Name
US Pharma Lab
Legal name
US Pharma Lab
Website
https://uspl.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
US Pharma Lab is a B2B contract manufacturer of premium dietary supplement ingredients, founded in 1996 in North Brunswick, NJ, and operating since 2023 as the North American hub of Italy's Biofarma Group. It serves supplement brands with turnkey development, probiotic manufacturing, and 12 dedicated packaging lines.
Ownership category
akta.pro rank

US Pharma Lab industry classification

Industry
Product category
Contract Dietary Supplement Manufacturing
NAICS
Food Manufacturing (311)
SIC
Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
akta.pro industry
PRIMARYCRADAGAC
Multivitamins & Daily Packs
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYAFAHAHAJ
Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes)
Agriculture & Food Production/Dairy Processing/Infant Formula & Specialized Dairy Nutrition Manufacturing
SECONDARYCRADAOAM
Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes)

Keywords

  • Contract dietary supplement manufacturing
  • Custom tablet development
  • Probiotic manufacturing services
  • Premix formulations
  • Turnkey packaging solutions

Where US Pharma Lab is headquartered

Location

Headquarters

HQ city
North Brunswick
HQ country
United States
HQ region
North America

Offices1 record

Markets served

US Pharma Lab business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Custom Dietary Supplement Manufacturing: B2B contract manufacturing services for dietary supplement brands, providing custom development, production, and packaging of premium supplement ingredients and finished products in various delivery forms.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

US Pharma Lab product offering

Product offering

Core offering

USPL is a custom developer, manufacturer, and supplier of premium dietary supplement ingredients, premixes, and finished products, serving nutraceutical brands across nine dosage formats (tablets, hard capsules, chewable/ODT, powders, beadlets, mini-tablets, probiotics, solid food supplements, and medical foods). The company also offers turnkey packaging solutions designed to address challenges in product formulation and stability for B2B clients.

Product overview

US Pharma Lab is a custom developer, manufacturer, and supplier of premium dietary supplement ingredients. The company offers a comprehensive portfolio of delivery forms including tri-layer and bi-layer tablets, extended-release/modified-release tablets, chewable and orally dispersible tablets (ODT), hard capsules, and customizable powders. The product portfolio is supported by proprietary technologies including taste & odor masking systems, beadlets, mini-tablets with personalized release technology, and Tablet-in-Capsule technology. US Pharma Lab specializes in probiotic-based supplements manufactured in dedicated controlled-environment facilities, along with solid food supplements and medical foods. The company provides complete turnkey operations including production and 12 dedicated packaging lines for bottles, cartons, blister cards, boxes, and stick packs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Tablets (Tri-layer/Bi-layer, Extended-Release, Modified-Release, Chewable, ODT) Custom tablet development and manufacturing covering tri-layer and bi-layer constructions, extended- and modified-release profiles, plus chewable and orally dispersible tablet (ODT) formats for nutraceutical and dietary supplement brand customers.
  • Hard Capsules Custom hard capsule manufacturing as one of USPL's core dosage formats for dietary supplement brands.
  • Powder Formulations (Bulk, Ready-to-Drink, Customizable) Development and production of bulk powders, ready-to-drink powder formulations, and customizable powder products for supplement and functional-food customers.
  • Beadlet Supplements Beadlet technology offering that enables delivery of actives in a beadlet form for dietary supplement brands seeking differentiated formats.
  • Mini-Tablets with Personalized Release Technology Mini-tablet dosage format using USPL's personalized release technology for nutraceutical customers seeking precise, customizable release profiles.
  • Probiotic Supplement Manufacturing Probiotic supplement manufacturing conducted in dedicated 25% relative humidity controlled rooms to protect probiotic viability and deliver reliable potency for brand customers.
  • Solid Food Supplements Solid food-form supplement products offered as one of USPL's nine dosage formats for nutraceutical and functional food brands.
  • Medical Foods Medical food products within USPL's portfolio, targeted at nutraceutical and clinical nutrition customers.
  • Turnkey Packaging Solutions Complete turnkey packaging services designed to address product-development challenges for B2B customers, including execution alongside custom manufacturing programs.

Quantifiable outcome

  • Global outreach spanning three continents

Companies that use US Pharma Lab

Customer profile

Segments1 record

Ideal customer profiles1 record

US Pharma Lab technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

US Pharma Lab partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Biofarma GroupcoreStrategic or Co-development Partner · 1 January 2023US Pharma Lab joined Biofarma Group in 2023, becoming part of a larger pharmaceutical manufacturing group with multiple manufacturing sites including facilities in Italy and France. The partnership provides USPL with enhanced global scale and resources while serving as Biofarma Group's North American headquarters and manufacturing hub.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

US Pharma Lab competitors and assessment

Company assessment

Direct peers

  • Biofarma Group: Parent company and direct CDMO peer. Biofarma Group operates multiple manufacturing sites across Italy and France producing dietary supplements, probiotics, and medical foods using the same delivery-form technologies (mini-tablets, beadlets, ODT) and certifications. Most direct comparable because it shares product formats, customer base (supplement brands), and regulatory playbook.
  • Glanbia Nutritionals: Provider of nutritional premixes, custom ingredient solutions, and finished supplement manufacturing for brand customers. Comparable to USPL's premix, ingredient supply, and contract manufacturing business, including customized formulations for supplement brands.
  • Procaps Group: Latin American CDMO specializing in softgel, capsule, and tablet dietary supplement manufacturing for global brands. Comparable to USPL as a turnkey supplement contract manufacturer serving multinational brand clients with advanced delivery forms.
  • Sirio Pharma: CDMO offering end-to-end development and manufacturing of dietary supplements including gummies, softgels, and probiotics. Comparable to USPL in turnkey contract manufacturing, probiotic capabilities, and serving supplement brand customers globally.

Broad incumbents

  • Aenova Group: Large European CDMO offering solid, semi-solid, and liquid dosage forms for pharmaceuticals and dietary supplements. Comparable to USPL as a contract developer and manufacturer serving brand clients with turnkey operations and multi-format capabilities, though Aenova is broader in pharma.
  • Catalent: Global CDMO with softgel, oral solid, and biologics capabilities serving pharma and consumer health. Overlaps with USPL in dietary supplement contract manufacturing, advanced oral dosage forms (including mini-tablet and modified-release technologies), and brand-client services.
  • Lonza Capsules & Health Ingredients: Lonza operates a major capsules and health ingredients business including CDMO services for dietary supplements with beadlet and lipid-based delivery technology. Direct overlap with USPL's beadlet, capsule, and probiotic ingredient capabilities serving supplement brand customers.
  • Recipharm: European-headquartered CDMO with solid dose and softgel capabilities for pharma and consumer health. Comparable to USPL in turnkey contract manufacturing of oral solid supplements and probiotics, though with a broader pharma mix.
  • Delpharm: French CDMO with multiple sites producing solid dosage forms including dietary supplements and probiotics for brand clients. Comparable as a multi-site contract manufacturer offering turnkey supplement production with strong European regulatory footprint.
  • Fareva: Global contract manufacturer with significant dietary supplement and probiotic capabilities across Europe and the Americas. Comparable to USPL in CDMO model, multi-format oral dose manufacturing, and probiotic specialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

US Pharma Lab social profiles

Digital presence

US Pharma Lab compliance and trust

Trust signal

Compliance12 records

US Pharma Lab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

US Pharma Lab leadership team

Management profile

Number of profiles

Profiles1 record

US Pharma Lab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

US Pharma Lab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about US Pharma Lab

What does US Pharma Lab do?

USPL is a custom developer, manufacturer, and supplier of premium dietary supplement ingredients, premixes, and finished products, serving nutraceutical brands across nine dosage formats (tablets, hard capsules, chewable/ODT, powders, beadlets, mini-tablets, probiotics, solid food supplements, and medical foods). The company also offers turnkey packaging solutions designed to address challenges in product formulation and stability for B2B clients.

Is US Pharma Lab a public or private company?

US Pharma Lab is a private company. It is classified as corporate owned and is currently operating.

When was US Pharma Lab founded?

US Pharma Lab was founded in 1996. It employs 101 to 250 people.

Where is US Pharma Lab based?

US Pharma Lab is headquartered in North Brunswick, United States, in the North America region.

How does US Pharma Lab make money?

One revenue line is on record: custom Dietary Supplement Manufacturing.

Who are US Pharma Lab's main competitors?

Direct peers on record are Biofarma Group, Glanbia Nutritionals, Procaps Group and Sirio Pharma. Broad incumbents are Aenova Group, Catalent, Lonza Capsules & Health Ingredients, Recipharm, Delpharm and Fareva.

Does US Pharma Lab have an API?

No public API is recorded for US Pharma Lab.

What industry is US Pharma Lab in?

US Pharma Lab's product category is Contract Dietary Supplement Manufacturing. Its primary akta.pro industry code is CRADAGAC, Multivitamins & Daily Packs, with a secondary code of CRADAGAE, Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BiofarmagroupIl gruppo Biofarma annuncia l'acquisizione di US Pharma LabBiofarma Group has signed a definitive agreement to acquire 100% of US Pharma Lab, Inc., an American nutraceutical services company with operations in the United States and China. This strategic acquisition establishes the first global Contract Development and Manufacturing Organization (CDMO) dedicated exclusively to the nutraceutical sector, combining production footprints in the USA, Europe, and China. The transaction is expected to close in the third quarter of 2023 and will be financed through a combination of debt and equity.FIRSTonlineBiofarma (Ardian) acquires 100% of the American US Pharma LabBiofarma, controlled by Ardian, has signed a definitive agreement to acquire 100% of US Pharma Lab from the Luhadia family for an undisclosed amount. The transaction, financed through debt and equity, is scheduled to close in the third quarter of 2023, creating the world's first toll manufacturer dedicated exclusively to nutraceutical products. This strategic move aims to expand Biofarma's global operational footprint across Italy, France, the United States, and China.Nutraceutical Business ReviewBiofarma acquires US Pharma Lab and focuses solely on nutraceuticalsBiofarma Group has entered into a definitive agreement to acquire 100% of US Pharma Lab, a CDMO specializing in nutraceuticals, with the transaction expected to close in the third quarter of 2023. The acquisition integrates US Pharma Lab's operations in the US and China with Biofarma's European footprint, creating the first global CDMO solely focused on nutraceuticals. Current shareholders will reinvest proceeds into an indirect parent company of Biofarma Group, cementing a partnership involving Ardian and the Scarpa family.HappeningsVaccine Distribution - Why reinvent the wheel?The author argues that the US should use its existing pharmaceutical supply chain for vaccine distribution, citing CDC data that over 48% of the population receives a prescription monthly. The proposal includes notifying patients via pharmacy, using pharmacy marketing, and a control room, with Israel's model as a reference.